This week Diagnostic Robotics announced that they have raised $45 million in Series B financing. This round was led by StageOne investors with participation from Mayo Clinic, Technion - Israel Institute of Technology, and Bradley Bloom, co-founder of Berkshire Partners. The company will also become a Mayo Clinic Platform portfolio company. This round brings the company's total financing to $85 million. Diagnostic Robotics uses AI based predictive models to help patients manage chronic conditions and reduce emergency room visits.

The Israeli startup, which has developed an AI platform that helps predict which patients will benefit from proactive interventions and improve the point of care, has doubled its valuation to several hundred million dollars since its last funding round in 2019